Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Bryce

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Applied Toxicology : JAT|January 7, 2016
Flow cytometric evaluation of the contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cellsSaura C Sahu, Joyce Njoroge, Steven M Bryce, et al.
Environmental and Molecular Mutagenesis|July 2, 2016
γH2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9Derek T Bernacki, Steven M Bryce, Jeffrey C Bemis, et al.
Environmental and Molecular Mutagenesis|April 15, 2022
In vitro human cell-based aneugen molecular mechanism assayNikki E Hall, Kyle Tichenor, Steven M Bryce, et al.
Mutation Research|September 10, 2010
Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationshipsSteven M Bryce, Svetlana L Avlasevich, Jeffrey C Bemis, et al.
Journal of Applied Toxicology : JAT|September 17, 2014
Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by a flow cytometric in vitro micronucleus assaySaura C Sahu, Joyce Njoroge, Steven M Bryce, et al.
Environmental and Molecular Mutagenesis|January 11, 2021
The use of benchmark dose uncertainty measurements for robust comparative potency analysesRyan P Wheeldon, Stephen D Dertinger, Steven M Bryce, et al.
Mutagenesis|June 7, 2015
Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus dataJeffrey C Bemis, John W Wills, Steven M Bryce, et al.
Environmental and Molecular Mutagenesis|February 11, 2020
3Rs-friendly approach to exogenous metabolic activation that supports high-throughput genetic toxicology testingShuchang Tian, Aiyana Cyr, Karen Zeise, et al.
Environmental and Molecular Mutagenesis|January 27, 2020
Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of CompoundsRyan P Wheeldon, Derek T Bernacki, Stephen D Dertinger, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 7, 2017
Investigating the Generalizability of the MultiFlow ® DNA Damage Assay and Several Companion Machine Learning Models With a Set of 103 Diverse Test ChemicalsSteven M Bryce, Derek T Bernacki, Stephanie L Smith-Roe, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Applied Toxicology : JAT|January 7, 2016
Flow cytometric evaluation of the contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cellsSaura C Sahu, Joyce Njoroge, Steven M Bryce, et al.
Environmental and Molecular Mutagenesis|July 2, 2016
γH2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9Derek T Bernacki, Steven M Bryce, Jeffrey C Bemis, et al.
Environmental and Molecular Mutagenesis|April 15, 2022
In vitro human cell-based aneugen molecular mechanism assayNikki E Hall, Kyle Tichenor, Steven M Bryce, et al.
Mutation Research|September 10, 2010
Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationshipsSteven M Bryce, Svetlana L Avlasevich, Jeffrey C Bemis, et al.
Journal of Applied Toxicology : JAT|September 17, 2014
Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by a flow cytometric in vitro micronucleus assaySaura C Sahu, Joyce Njoroge, Steven M Bryce, et al.
Environmental and Molecular Mutagenesis|January 11, 2021
The use of benchmark dose uncertainty measurements for robust comparative potency analysesRyan P Wheeldon, Stephen D Dertinger, Steven M Bryce, et al.
Mutagenesis|June 7, 2015
Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus dataJeffrey C Bemis, John W Wills, Steven M Bryce, et al.
Environmental and Molecular Mutagenesis|February 11, 2020
3Rs-friendly approach to exogenous metabolic activation that supports high-throughput genetic toxicology testingShuchang Tian, Aiyana Cyr, Karen Zeise, et al.
Environmental and Molecular Mutagenesis|January 27, 2020
Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of CompoundsRyan P Wheeldon, Derek T Bernacki, Stephen D Dertinger, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 7, 2017
Investigating the Generalizability of the MultiFlow ® DNA Damage Assay and Several Companion Machine Learning Models With a Set of 103 Diverse Test ChemicalsSteven M Bryce, Derek T Bernacki, Stephanie L Smith-Roe, et al.
Pageof 4